EyeCyte Company

EyeCyte is engaged in the development of therapeutics for the treatment of neovascular and degenerative retinal diseases.
EyeCyte, Inc. is working with Pfizer's Bioinnovation and io therapeutics Center and The Scripps Research Institute to develop novel therapeutics to treat neovascular and degenerative retinal disease.
Technology: Regenerative medicine - cell therapy
Industry: Regenerative Medicine
Headquarters: La Jolla
Founded Date: 2005
Employees Number: 1-10
Funding Status: Early Stage Venture

Visit Website
swaymire@eyecyte.com
Register and Claim Ownership